ArticleClinical case reports2023

Successful adalimumab graded challenge after allergic delayed reaction to golimumab in a woman with rheumatoid arthritis.

Federica Rivolta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.